Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Target GroupCBDY Gross Margin % is 21.84% as of Mar. 2026, which is 55% below its 10-year median of 48.89. The stock has 3 warning signs investors should review. Among 940 Drug Manufacturers companies, Target Group ranks worse than 57.02% on this metric.
Target Group (OTCPK:CBDY) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Target Group had a gross margin of 21.84% for the quarter that ended in Mar. 2026 => Competition eroding margins
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Target Group Gross Margin % Related Terms
Target Group Gross Margin % Historical Data
* Premium members only.
The historical data trend for Target Group's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CBDY vs IMCC, GRPS, GCAN: Gross Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Target Group's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Target Group Gross Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Target Group's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Target Group's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Target Group (CBDY) has a Gross Margin % of 21.84% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Target Group and its competitors. This is 55% below median its historical median of 48.89. Over the past decade, Target Group's Gross Margin % has ranged from 16.67 to 56.51. According to the industry distribution chart, Target Group ranks #536 out of 940 companies in the Drug Manufacturers industry, placing it in the top 57%.
Is Target Group's Gross Margin % too high?
Target Group's current Gross Margin % of 21.84% is 55% below median its 10-year median of 48.89. Over the past 10 years, this metric has ranged from a low of 16.67 to a high of 56.51. The Drug Manufacturers industry median Gross Margin % is 48.35. Target Group's value of 21.84% is 54.8% below this industry median. Based on the distribution chart, Target Group ranks #536 out of 940 companies in the Drug Manufacturers industry, which is below the industry midpoint.
How does Target Group's Gross Margin % compare to IMCC and GRPS?
According to the Drug Manufacturers industry distribution chart, Target Group ranks #536 out of 940 companies for Gross Margin %. This places Target Group in the lower half of its industry. The industry median Gross Margin % is 48.35. Target Group's value of 21.84% is 54.8% below this benchmark. Historically, Target Group's own Gross Margin % has ranged from 16.67 to 56.51 over the past decade. While the company's 10-year median is 48.89 vs. the industry median of 48.35, Target Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.35, based on 940 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Target Group's current Gross Margin % of 21.84% is 54.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Target Group and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.35 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Target Group's current Gross Margin % is 21.84%, which is 55% below median its own 10-year median of 48.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Target Group stock overvalued right now?
Target Group (CBDY) has a current Gross Margin % of 21.84%. The current Gross Margin % is 21.84%, which is 55% below median its 10-year median of 48.89 and 54.8% below the Drug Manufacturers industry median of 48.35. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Target Group (CBDY), the current Gross Margin % is 21.84% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Target Group Inc is engaged in the cultivation, processing, and distribution of curated cannabis products for the adult-use medical and recreational cannabis market in Canada. The company generates revenue from the sale of Wisp vaporizer and Wisp pod units. Its product manufacturing includes Cannabis flower pods for vaporizer use, , extract pods for vaporizer use, Cannabis pre-rolls, K-Cup infused coffee and tea pods, Infused cannabis beverages, etc. Geographically, the company operates in Canada, Israel, Germany, Australia, UK and Poland region generating key revenue from Canada.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CBDY has been successfully added to your 
